UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000017862
Receipt number R000020696
Scientific Title Significance of WT1 mRNA in the clinical course of lower-risk myelodysplastic syndromes.
Date of disclosure of the study information 2015/06/15
Last modified on 2015/06/10 18:23:48

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Significance of WT1 mRNA in the clinical course of lower-risk myelodysplastic syndromes.

Acronym

Significance of WT1 mRNA in the clinical course of lower-risk myelodysplastic syndromes.

Scientific Title

Significance of WT1 mRNA in the clinical course of lower-risk myelodysplastic syndromes.

Scientific Title:Acronym

Significance of WT1 mRNA in the clinical course of lower-risk myelodysplastic syndromes.

Region

Japan


Condition

Condition

lower-risk myelodysplastic syndromes

Classification by specialty

Hematology and clinical oncology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To examine prognostic impacts of the value of WT1 mRNA in lower-risk MDS patients.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Impacts of the value of WT1 mRNA on 2 year overall survival

Key secondary outcomes



Base

Study type


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Other

Interventions/Control_1

blood collection

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who were diagnosed with MDS or ICUS, and meets the categories below;

1: classified as RCUD, RCMD, MDS-U or ICUS
2: more than 20 years old
3: from whom we can obtain documented informed consent.

Key exclusion criteria

None

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Takahiro Suzuki

Organization

Jichi Medical University

Division name

Division of Hematology, Department of Medicine

Zip code


Address

3311-1 Yakushiji, Shimotsuke, Tochigi

TEL

0285-58-7353

Email

tasuzuki@jichi.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Takahiro Suzuki

Organization

Jichi Medical University

Division name

Division of Hematology, Department of Medicine

Zip code


Address

3311-1 Yakushiji, Shimotsuke, Tochigi

TEL

0285-58-7353

Homepage URL


Email

tasuzuki@jichi.ac.jp


Sponsor or person

Institute

Jichi Medical University

Institute

Department

Personal name



Funding Source

Organization

National Research Group on Idiopathic Bone Marrow Failure Syndromes in Japan

Organization

Division

Category of Funding Organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 06 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2014 Year 05 Month 21 Day

Date of IRB


Anticipated trial start date

2014 Year 05 Month 21 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 06 Month 10 Day

Last modified on

2015 Year 06 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020696


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name